Idiopathic thrombocytopenic purpura: guidance amid uncertainty.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 9830783.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical guidelines for treating ITP are based on the consensus of an expert panel, as randomized trials are lacking. Newer genetically engineered treatments hold promise but await definitive study.